Hepatocellular carcinoma

Researchers engineer specialized T cells that can transiently and effectively attack liver cancer cells even in the presence of immunosuppressive drugs.

Researchers reveal that the buildup of branched-chain amino acids fuels the growth and aggressiveness of liver cancer cells.

A two-pronged genetic manipulation of T cells of the human immune system could lead to more effective cancer treatments

Insights into the growth of liver
cancer tumors and their genetic diversity could inform future personalized
cancer therapies

A cell-surface protein overexpressed in liver cancer offers a promising target for therapy

New research sheds light on the molecular mechanisms by which a virus contributes to cancer